However, it was relatively easier to evaluate stromal tumor-infiltrating lymphocytes or PD-L1 expression than to evaluate intraepithelial tumor-infiltrating lymphocytes or PD-L1 expression in our experience. This evidence concerns the gene CD274 and neoplasm.